BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29582646)

  • 1. A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population.
    Mir R; Javid J; Al Balawi IA; Alkharsah KR; Hadi MA; Rahman MA; Hamoud E; Al Alawi Y; Al Zahrani ABM; Abu-Duhier FM
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):859-866. PubMed ID: 29582646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer.
    Dorairaj JJ; Salzman DW; Wall D; Rounds T; Preskill C; Sullivan CA; Lindner R; Curran C; Lezon-Geyda K; McVeigh T; Harris L; Newell J; Kerin MJ; Wood M; Miller N; Weidhaas JB
    BMC Cancer; 2014 Jun; 14():421. PubMed ID: 24915755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
    Brewster BL; Rossiello F; French JD; Edwards SL; Wong M; Wronski A; Whiley P; Waddell N; Chen X; Bove B; ; Hopper JL; John EM; Andrulis I; Daly M; Volorio S; Bernard L; Peissel B; Manoukian S; Barile M; Pizzamiglio S; Verderio P; Spurdle AB; Radice P; Godwin AK; Southey MC; Brown MA; Peterlongo P
    Hum Mutat; 2012 Dec; 33(12):1665-75. PubMed ID: 22753153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of microRNA-423 Gene Variability in Breast Cancer Progression in Saudi Arabia.
    Mir R; Al Balawi IA; Duhier FMA
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2581-2589. PubMed ID: 30256064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.
    Erturk E; Cecener G; Polatkan V; Gokgoz S; Egeli U; Tunca B; Tezcan G; Demirdogen E; Ak S; Tasdelen I
    Asian Pac J Cancer Prev; 2014; 15(19):8319-24. PubMed ID: 25339023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Impact of Vascular Endothelial Growth Factor Gene Variation (-2578C>A) on Breast Cancer Susceptibility in Saudi Arabia: a Case-Control Study.
    Al Balawi IA; Mir R; Abu-Duhier FM
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1135-1143. PubMed ID: 29699375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Effects of Vascular Endothelial Growth Factor A (VEGF-A) and Its Association with Disease Progression in Breast Cancer Population of Saudi Arabia.
    Albalawi IA; Mir R; Abu Duhier FM
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):139-145. PubMed ID: 31983176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel variants in the 3'UTR of the BRCA1 gene in familial breast and/or ovarian cancer.
    Lheureux S; Lambert B; Krieger S; Legros A; Vaur D; Denoyelle C; Berthet P; Poulain L; Hardouin A
    Breast Cancer Res Treat; 2011 Feb; 125(3):885-91. PubMed ID: 20848184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Evaluation of PROGINS Mutation in Progesterone Receptor Gene and Determination of its Frequency, Distribution Pattern and Association with Breast Cancer Susceptibility in Saudi Arabia.
    Albalawi IA; Mir R; Abu-Duhier FM
    Endocr Metab Immune Disord Drug Targets; 2020; 20(5):760-770. PubMed ID: 31763970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.
    Hollestelle A; Pelletier C; Hooning M; Crepin E; Schutte M; Look M; Collee JM; Nieuwlaat A; Dorssers LC; Seynaeve C; Aulchenko YS; Martens JW; van den Ouweland AM; Weidhaas JB
    Breast Cancer Res Treat; 2011 Jul; 128(1):79-84. PubMed ID: 20676756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of
    Alhadheq AM; Purusottapatnam Shaik J; Alamri A; Aljebreen AM; Alharbi O; Almadi MA; Alhadeq F; Azzam NA; Semlali A; Alanazi M; Bazzi MD; Reddy Parine N
    Dis Markers; 2016; 2016():8289293. PubMed ID: 27746584
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin D Receptor Gene Polymorphism: Association with Susceptibility to Early-Onset Breast Cancer in Iranian, BRCA1/2-Mutation Carrier and non-carrier Patients.
    Shahabi A; Alipour M; Safiri H; Tavakol P; Alizadeh M; Milad Hashemi S; Shahabi M; Halimi M
    Pathol Oncol Res; 2018 Jul; 24(3):601-607. PubMed ID: 28780723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk.
    Pelletier C; Speed WC; Paranjape T; Keane K; Blitzblau R; Hollestelle A; Safavi K; van den Ouweland A; Zelterman D; Slack FJ; Kidd KK; Weidhaas JB
    Cell Cycle; 2011 Jan; 10(1):90-9. PubMed ID: 21191178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Evaluation of HIF-1α Gene Variation and Determination of Its Frequency and Association with Breast Cancer Susceptibility in Saudi Arabia.
    Mir R; Abu-Duhier FM; Albalawi IA
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):544-553. PubMed ID: 32914726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association of BRCA1 and BRCA2 variants with breast cancer in an ethnic population of Saudi Arabia, an emerging high-risk area.
    Hasan TN; Shafi G; Syed NA; Alsaif MA; Alsaif AA; Alshatwi AA
    Asian Pac J Cancer Prev; 2013; 14(10):5671-4. PubMed ID: 24289560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Receptor 1 Gene (ESR1) rs2234693 Polymorphism and Breast Cancer Risk in Saudi Women.
    Al-Amri RJ; Alotibi MKH; Al-Raddadi RI; Shebli WTY; Fallatah EIY; Alhujaily AS; Mohamed HS
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3235-3240. PubMed ID: 33247680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
    Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
    Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation.
    Jakubowska A; Gronwald J; Górski B; Huzarski T; Byrski T; Benner A; Lubiński J; Scott RJ; Hamann U
    Breast Cancer Res Treat; 2007 Jul; 104(1):67-74. PubMed ID: 17004108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients.
    Sun J; Meng H; Yao L; Lv M; Bai J; Zhang J; Wang L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    Clin Cancer Res; 2017 Oct; 23(20):6113-6119. PubMed ID: 28724667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.